Cross-linked amylose tablets containing α-amylase: An enzymatically-controlled drug release system

Journal of Controlled Release

Volumn 60, Issue 2-3, 1999, Pages 161-167

  Dumoulin, Yves ^a   Cartilier, Louis H ^a   Mateescu, Mircea A ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Amylase; Controlled release; Cross linked amylose; Hydrogel; Tablet

Indexed keywords

ACETANILIDE; AMYLASE; AMYLOSE; PARACETAMOL; THEOPHYLLINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDRATION; HYDROLYSIS; PRIORITY JOURNAL; TABLET COMPRESSION; ULTRAVIOLET SPECTROPHOTOMETRY;

ALPHA-AMYLASE; AMYLOSE; ANTI-INFLAMMATORY AGENTS; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; HYDROGEL; HYDROLYSIS; TABLETS; TIME FACTORS;

EID: 0032808810     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00065-6     Document Type: Article

References (17)

1. Heller J., Baker R.W. Theory and practice of controlled drug delivery from bioerodible polymers. Baker R.W. Controlled Release of Bioactive Materials. 1980;1-17 Academic Press, New York.
2. Heller J. Use of enzymes and bioerodible polymers in self regulated and triggered drug delivery systems. Kost J. Pulse and Self-Regulated Drug Delivery. 1990;93-108 CRC Press, Boca Raton. Chapter 5.
3. Kost J., Shefer S. Chemically-modified polysaccharides for enzymatically-controlled oral drug delivery. Biomaterials. 11:1990;695-698.
4. Biliaderis C.G. The structure and interactions of starch with food constituents. Can. J. Physiol. Pharmacol. 69:1991;60-78.
5. Nakano M., Nakazono N., Inotsume N. Preparation and evaluation of sustained release tablets prepared with α-starch. Chem. Pharm. Bull. 35:1987;4346-4350.
6. Trimnell D., Shasha B.S., Otey F.H. The effect of α-amylase upon release of trifluralin encapsulated in starch. J. Control. Release. 1:1985;183-190.
7. Lenaerts V., Dumoulin Y., Mateescu M.A. Controlled release of theophylline from cross-linked amylose tablets. J. Control. Release. 15:1991;39-46.
8. Schell H., Mateescu M.A., Bentia T., Jifcu A. α-Amylase purification and separation from glucoamylase by affinity chromatography on cross-linked amylose. Anal. Lett. (New York). 14:1981;1501-1514.
9. M.A. Mateescu, Y. Dumoulin, L. Cartilier, V. Lenaerts, Cross-linked polyhydroxylic material for enzymatically controlled drug release. Int. Pat. (PCT: W094/02121/1992). US Pat. 5 603 956/1997.
10. Dumoulin Y., Cartilier L., Preda M., Alex S., Lenaerts V., Mateescu M.A. Cross-linked amylose as matrix for drug controlled release. X-ray and FT-IR analysis. Proc. Int. Symp. Control. Rel. Bioact. Mater. 21:1994;660-661.
11. Moussa I., Cartilier L. Characterization of moving fronts in cross-linked amylose matrices by image analysis. J. Control. Release. 42:1996;47-55.
12. Noelting G., Bernfeld P. Diastatic enzymes. III. β-amylase: Determination of activity and control of absence of α-amylase. Helv. Chim. Acta. 31:1948;286-290.
13. Peppas N.A. Analysis of fickian and non-fickian drug release from polymers. Pharm. Acta Helv. 60:1985;110-111.
14. Moussa I., Cartilier L. The influence of cross-linking degree on drug dissolution, water uptake and swelling profiles of cross-linked amylose matrices. Proc. 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology :1995;241-242 APGI/APV.
15. Mateescu M.A., Schell H.D. A new amyloclastic method for the selective determination of α-amylase using cross-linked amylose as an insoluble substrate. Carbohydr. Res. (Amsterdam). 124:1983;319-323.
16. Lenaerts V., Moussa I., Dumoulin Y., Mebsout F., Chouinard F., Szabo P., Mateescu M.A., Cartilier L., Marchessault R. Cross-linked high amylose starch for controlled release of drugs: recent advances. J. Control. Release. 53:1998;225-234.
17. Melia C.D. Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit. Rev. Ther. Drug Carrier Systems. 8:1991;395-421.